Myelodysplastický syndrom
- doc. MUDr. Jaroslav Čermák, CSc., Ústav hematologie a krevní transfuze, Praha
Guidelines for the diagnosis and management of adult myelodysplastic syndromes
Otevřít | 2014 | MUDr. Libor Červinek
How we treat lower-risk myelodysplastic syndromes
Otevřít | 2013 | MUDr. Libor Červinek
Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996)
Otevřít | 2009 | MUDr. Marie Langová
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
Otevřít | 2009 | MUDr. Štěpán Hrabovský
Factors affecting response and survival in patients with myelodysplasia treated with immunosuppresive therapy
Otevřít | 2008 | MUDr. František Folber
Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome
Otevřít | 2008 | MUDr. František Folber
Copper deficiency: an important consideration in the differential diagnosis of myelodysplastic syndrome
Otevřít | 2007 | MUDr. František Folber
Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia
Otevřít | 2007 | MUDr. František Folber
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes
Otevřít | 2007 | MUDr. František Folber
Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia
Otevřít | 2006 | MUDr. František Folber
Decitabine improves patient outcomes in myelodysplastic syndromes results of a phase III randomised study
Otevřít | 2006 | MUDr. František Folber
Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion
Otevřít | 2006 | MUDr. František Folber
Further analysis of trial with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B
Otevřít | 2006 | MUDr. František Folber
Efficacy of lenalidomide in myelodysplastic syndromes
Otevřít | 2005 | MUDr. František Folber